THE KEY TO PROSTATE CANCER
When initially diagnosed with prostate cancer, the first step is to seek information. The "Paradox of Choice" can be diminished by staging the cancer accurately and a deluge of data. With a short, self-administered prostate cancer staging quiz, Key directs readers to targeted information that is stage-specific.
INVASION OF THE PROSTATE SNATCHERS
Every year almost a quarter of a million confused and frightened American men are tossed into a prostate cancer cauldron stirred by salespeople representing a multibillion-dollar industry. In this flourishing business, the radical prostatectomy is still the most widely recommended treatment option.
WRITTEN BY RALPH BLUM, my co-author Invasion of the Prostate Snatchers book. Nearly every industry on God’s good earth has become mechanized in some form or another over the past 200 years, and the Prostate Cancer Industry—yes, it’s an industry, folks—is no exception. Enter the da Vinci Robot. In 2009,
BY MARK SCHOLZ, MD & LIZ GRAVES For many men, surgery seems like the best option: “A quick operation and the problem will be gone.” While this thinking may apply to other aspects of life, such as removing the brown parts of a banana before you eat it, or trimming
The PROSTATE PROS podcast helps men keep updated with the latest in prostate cancer research and helps them understand all the possible treatment options. With PROSTATE PROS, anyone can be a prostate cancer expert and avoid prostate cancer pitfalls. Episodes are 20-30 minutes in length and will be released the first Monday of each month.
Patients frequently ask their physicians, “Am I stage A, B, C or D,” without realizing that the original purpose of a lettering system was simply to provide a clinical stage that could guide urologists in the selection of candidates for surgery. While clinical stage matters, a combination of PSA level, clinical stage plus the Gleason grade is a better way to assess disease status. So rather than using clinical stage alone, it’s best to incorporate all three factors together—PSA, Gleason and stage—to break prostate cancer down into five broad categories called the STAGES OF BLUE.
Studies show that treatment choices based on partial information often lead to regret. Patients struggle to pinpoint correct knowledge amidst a deluge of data overload. KEY directs readers to targeted information that is stage-specific. Available at Barnes and Noble, Apple, Amazon (paperback and e-book).
No More Unnecessary Biopsies, Radical Treatment or Loss of Sexual Potency
Ralph Blum’s account of his personal struggle, together with Dr. Mark Scholz’s presentation of newscientific advances, provides convincing evidence that this noninvasive approach can be crucial in preventing tens of thousands of men from being overtreated every year.
The Prostate Cancer Research Institute's mission is to improve the quality of prostate cancer patients’ and caregivers’ lives by supporting research and disseminating information that educates and empowers patients, families, and the medical community. CO-FOUNDED BY MARK SCHOLZ, MD